Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Biodexa Pharmaceuticals Plc ADR (BDRX)

Biodexa Pharmaceuticals Plc ADR (BDRX)
1.3500 x 45 1.4200 x 2
Post-market by (Cboe BZX)
1.4000 +0.0200 (+1.45%) 04/22/25 [NASDAQ]
1.3500 x 45 1.4200 x 2
Post-market 1.3501 -0.0499 (-3.56%) 19:08 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.3200
Day High
1.4300
Open 1.3300
Previous Close 1.3800 1.3800
Volume 63,600 63,600
Avg Vol 1,229,685 1,229,685
Stochastic %K 33.61% 33.61%
Weighted Alpha -91.59 -91.59
5-Day Change -0.2500 (-15.15%) -0.2500 (-15.15%)
52-Week Range 1.1400 - 73.9975 1.1400 - 73.9975
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,431
  • Shares Outstanding, K 36,544
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,320 K
  • EBIT $ 0 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.70
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1400 +22.81%
on 03/31/25
Period Open: 1.7700
1.9100 -26.70%
on 04/04/25
-0.3700 (-20.90%)
since 03/21/25
3-Month
1.1400 +22.81%
on 03/31/25
Period Open: 4.1600
9.2000 -84.78%
on 02/10/25
-2.7600 (-66.35%)
since 01/22/25
52-Week
1.1400 +22.81%
on 03/31/25
Period Open: 19.1250
73.9975 -98.11%
on 05/21/24
-17.7250 (-92.68%)
since 04/22/24

Most Recent Stories

More News
With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter

CARDIFF, UNITED KINGDOM / ACCESS Newswire / March 19, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the...

BDRX : 1.4000 (+1.45%)
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment...

BDRX : 1.4000 (+1.45%)
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks

The drug, a proprietary encapsulated form of rapamycin, is being developed for familial adenomatous polyposis (FAP), a condition that, if left untreated, universally leads to colorectal cancer.

BDRX : 1.4000 (+1.45%)
Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical...

BDRX : 1.4000 (+1.45%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

DRUG : 33.50 (+5.05%)
BDRX : 1.4000 (+1.45%)
LLY : 827.54 (+1.16%)
PTN : 0.2100 (-9.09%)
CRDF : 3.05 (+8.16%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End

/PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group...

DRUG : 33.50 (+5.05%)
BDRX : 1.4000 (+1.45%)
LLY : 827.54 (+1.16%)
PTN : 0.2100 (-9.09%)
CRDF : 3.05 (+8.16%)

Business Summary

BIODEXA PHARMA is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3(TM) platform for delivering therapeutics across the blood-brain barrier and the treatment of central nervous system...

See More

Key Turning Points

3rd Resistance Point 1.5567
2nd Resistance Point 1.4933
1st Resistance Point 1.4467
Last Price 1.4000
1st Support Level 1.3367
2nd Support Level 1.2733
3rd Support Level 1.2267

See More

52-Week High 73.9975
Fibonacci 61.8% 46.1659
Fibonacci 50% 37.5687
Fibonacci 38.2% 28.9716
Last Price 1.4000
52-Week Low 1.1400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro